Parasite - The Journal
banner
parasitejournal.bsky.social
Parasite - The Journal
@parasitejournal.bsky.social
Parasite: An international open-access, peer-reviewed, online journal publishing parasitology.
2024 Impact Factor: 2.4
🧪https://www.parasite-journal.org/
Pinned
Parasite - The Journal is now on Bluesky.

Follow us for news about new papers in press or published.
All papers are open-access: do not hesitate to click on links, you won't find a paywall!
www.parasite-journal.org
New paper today:
Diversity and abundance of Culicoides on goat and cattle farms in the southern part of the Republic of Korea 🧪
doi.org/10.1051/para...
February 10, 2026 at 9:30 AM
Reposted by Parasite - The Journal
Molecular evidence on phenotypic variation in Rhadinorhynchus cololabis
When looks are misleading: this study shows that dramatic differences in parasite spines don’t mean different species. DNA helps untangle hidden diversity and avoid taxonomic traps.🧪
doi.org/10.1051/para...
February 8, 2026 at 2:17 PM
Reposted by Parasite - The Journal
One year ago: Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions
This review explores how Cryptosporidium interacts with host cells and highlights emerging drug targets and therapies for a disease still lacking effective treatment.🧪
doi.org/10.1051/para...
February 8, 2026 at 2:21 PM
Reposted by Parasite - The Journal
One year ago: The impact of schistosomiasis on the Global Disease Burden
Based on GBD 2021 data, this analysis tracks global trends and forecasts for schistosomiasis, revealing overall progress alongside enduring inequalities across regions.
doi.org/10.1051/para...
February 8, 2026 at 2:24 PM
One year ago: The impact of schistosomiasis on the Global Disease Burden
Based on GBD 2021 data, this analysis tracks global trends and forecasts for schistosomiasis, revealing overall progress alongside enduring inequalities across regions.
doi.org/10.1051/para...
February 8, 2026 at 2:24 PM
One year ago: Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions
This review explores how Cryptosporidium interacts with host cells and highlights emerging drug targets and therapies for a disease still lacking effective treatment.🧪
doi.org/10.1051/para...
February 8, 2026 at 2:21 PM
Molecular evidence on phenotypic variation in Rhadinorhynchus cololabis
When looks are misleading: this study shows that dramatic differences in parasite spines don’t mean different species. DNA helps untangle hidden diversity and avoid taxonomic traps.🧪
doi.org/10.1051/para...
February 8, 2026 at 2:17 PM
Reposted by Parasite - The Journal
𝗧𝗼𝘅𝗼𝗽𝗹𝗮𝘀𝗺𝗮 𝗴𝗼𝗻𝗱𝗶𝗶 𝗮𝘀 𝗮 𝗱𝗿𝘂𝗴 𝗳𝗼𝗿 𝗮𝗻𝘁𝗶-𝘁𝘂𝗺𝗼𝗿 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆
From pathogen to potential cancer therapy: this review explores how T. gondii activates antitumor immunity, reshapes the tumor microenvironment, and the challenges limiting clinical translation. 🧪
doi.org/10.1051/para...
February 6, 2026 at 10:06 AM
Reposted by Parasite - The Journal
𝗚𝗹𝗼𝘀𝘀𝗶𝗻𝗮 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗥𝗲𝗽𝘂𝗯𝗹𝗶𝗰 𝗼𝗳 𝘁𝗵𝗲 𝗖𝗼𝗻𝗴𝗼
Using MALDI-TOF MS, this new study demonstrates a fast and reliable approach for identifying Glossina species from Congo, highlighting its strengths for vector surveillance and its limits for infection detection.🧪
doi.org/10.1051/para...
February 6, 2026 at 10:16 AM
𝗚𝗹𝗼𝘀𝘀𝗶𝗻𝗮 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗥𝗲𝗽𝘂𝗯𝗹𝗶𝗰 𝗼𝗳 𝘁𝗵𝗲 𝗖𝗼𝗻𝗴𝗼
Using MALDI-TOF MS, this new study demonstrates a fast and reliable approach for identifying Glossina species from Congo, highlighting its strengths for vector surveillance and its limits for infection detection.🧪
doi.org/10.1051/para...
February 6, 2026 at 10:16 AM
𝗧𝗼𝘅𝗼𝗽𝗹𝗮𝘀𝗺𝗮 𝗴𝗼𝗻𝗱𝗶𝗶 𝗮𝘀 𝗮 𝗱𝗿𝘂𝗴 𝗳𝗼𝗿 𝗮𝗻𝘁𝗶-𝘁𝘂𝗺𝗼𝗿 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆
From pathogen to potential cancer therapy: this review explores how T. gondii activates antitumor immunity, reshapes the tumor microenvironment, and the challenges limiting clinical translation. 🧪
doi.org/10.1051/para...
February 6, 2026 at 10:06 AM
We have updated our Instructions for Authors
We hope you will find them simpler and easier to follow. 🧪
www.parasite-journal.org/author-infor...
February 6, 2026 at 9:37 AM
Reposted by Parasite - The Journal
𝗡𝗲𝘄 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼𝗱𝗮𝘆:
Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives 🧪
doi.org/10.1051/para...
February 5, 2026 at 9:08 AM
Reposted by Parasite - The Journal
𝗡𝗲𝘄 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼𝗱𝗮𝘆:
Glossina from the Republic of the Congo: species identification by MALDI-TOF MS and research of associated micro-organisms 🧪
doi.org/10.1051/para...
February 5, 2026 at 9:16 AM
Now in press:
Host genetic background influences the severity of disease in Schistosoma haematobium infections 🧪
Soon... www.parasite-journal.org
February 5, 2026 at 3:05 PM
Now in press:
Immunological surveillance using anti-gSG6-P1 IgG biomarker reveals spatio-temporal dynamics of Anopheles exposure and gaps in malaria risk assessment in the Greater Mekong Subregion 🧪
Soon... www.parasite-journal.org
February 5, 2026 at 9:38 AM
𝗡𝗲𝘄 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼𝗱𝗮𝘆:
Glossina from the Republic of the Congo: species identification by MALDI-TOF MS and research of associated micro-organisms 🧪
doi.org/10.1051/para...
February 5, 2026 at 9:16 AM
𝗡𝗲𝘄 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼𝗱𝗮𝘆:
Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives 🧪
doi.org/10.1051/para...
February 5, 2026 at 9:08 AM
Now in press: 🧪
Clonorchis sinensis and cholangiocarcinoma: molecular mechanisms and biomarker advances
Soon... www.parasite-journal.org
February 5, 2026 at 8:15 AM
𝗖𝗼𝗻𝗴𝗿𝗲̀𝘀 𝗮𝗻𝗻𝘂𝗲𝗹:
Société Française de Parasitologie
Société Française de Mycologie Médicale
5ème Journée Franco-Maghrébine de Parasitologie-Mycologie
Marseille, 28 au 30 avril 2026 🧪
🔗 sfp-sfmm2026.org
January 30, 2026 at 8:11 AM
Now in press in Parasite: 🧪🦟
𝗣𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 𝗮𝗻𝗱 𝗺𝗼𝘂𝗻𝘁𝗶𝗻𝗴 𝗽𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝗶𝗻𝗲 𝘀𝗮𝗻𝗱 𝗳𝗹𝗶𝗲𝘀: 𝗮 𝗰𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀 𝗴𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲
This paper will be published with translations in several languages!
Stay tuned... www.parasite-journal.org
January 29, 2026 at 3:11 PM
Reposted by Parasite - The Journal
New study:
NexGard® Plus shows strong field efficacy against canine sarcoptic mange.
Afoxolaner + moxidectin + pyrantel eliminated Sarcoptes scabiei (100%) after 2 treatments, with rapid clinical improvement. 🐶🔬🧪
doi.org/10.1051/para...
January 23, 2026 at 9:56 AM
Reposted by Parasite - The Journal
New paper today: 🧪
Comparative assessment of immunochromatographic test kits using low-molecular-weight antigens from cyst fluids of two different genotypes of Taenia solium for serodiagnosis of human cysticercosis
doi.org/10.1051/para...
January 23, 2026 at 9:16 AM
New study:
NexGard® Plus shows strong field efficacy against canine sarcoptic mange.
Afoxolaner + moxidectin + pyrantel eliminated Sarcoptes scabiei (100%) after 2 treatments, with rapid clinical improvement. 🐶🔬🧪
doi.org/10.1051/para...
January 23, 2026 at 9:56 AM
New paper today: 🧪
Comparative assessment of immunochromatographic test kits using low-molecular-weight antigens from cyst fluids of two different genotypes of Taenia solium for serodiagnosis of human cysticercosis
doi.org/10.1051/para...
January 23, 2026 at 9:16 AM